CZ299701B6 - Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek - Google Patents

Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek Download PDF

Info

Publication number
CZ299701B6
CZ299701B6 CZ20021562A CZ20021562A CZ299701B6 CZ 299701 B6 CZ299701 B6 CZ 299701B6 CZ 20021562 A CZ20021562 A CZ 20021562A CZ 20021562 A CZ20021562 A CZ 20021562A CZ 299701 B6 CZ299701 B6 CZ 299701B6
Authority
CZ
Czechia
Prior art keywords
treosulfan
use according
conditioning
bone marrow
body surface
Prior art date
Application number
CZ20021562A
Other languages
Czech (cs)
English (en)
Other versions
CZ20021562A3 (cs
Inventor
Baumgart@Joachim
Original Assignee
Medac Gesellschaft Für Klinische Spezialpräparatembh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft Für Klinische Spezialpräparatembh filed Critical Medac Gesellschaft Für Klinische Spezialpräparatembh
Publication of CZ20021562A3 publication Critical patent/CZ20021562A3/cs
Publication of CZ299701B6 publication Critical patent/CZ299701B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
CZ20021562A 1999-11-05 2000-11-03 Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek CZ299701B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19953517A DE19953517C1 (de) 1999-11-05 1999-11-05 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation

Publications (2)

Publication Number Publication Date
CZ20021562A3 CZ20021562A3 (cs) 2002-10-16
CZ299701B6 true CZ299701B6 (cs) 2008-10-22

Family

ID=7928187

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20021562A CZ299701B6 (cs) 1999-11-05 2000-11-03 Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek

Country Status (16)

Country Link
US (1) US7199162B1 (cg-RX-API-DMAC7.html)
EP (1) EP1227808B1 (cg-RX-API-DMAC7.html)
JP (1) JP4846151B2 (cg-RX-API-DMAC7.html)
AT (1) ATE251455T1 (cg-RX-API-DMAC7.html)
AU (1) AU777527B2 (cg-RX-API-DMAC7.html)
BG (1) BG65845B1 (cg-RX-API-DMAC7.html)
CA (1) CA2389896C (cg-RX-API-DMAC7.html)
CZ (1) CZ299701B6 (cg-RX-API-DMAC7.html)
DE (2) DE19953517C1 (cg-RX-API-DMAC7.html)
EA (1) EA004543B1 (cg-RX-API-DMAC7.html)
ES (1) ES2208435T3 (cg-RX-API-DMAC7.html)
HU (2) HU227332B1 (cg-RX-API-DMAC7.html)
NO (2) NO329616B1 (cg-RX-API-DMAC7.html)
PL (1) PL212132B1 (cg-RX-API-DMAC7.html)
UA (1) UA73961C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001032154A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237146A1 (de) * 2002-08-13 2004-03-04 Medac Gesellschaft für klinische Spezialpräparate mbH Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose
JP7431815B2 (ja) * 2018-09-26 2024-02-15 メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク トレオスルファンの結晶形
PT4257122T (pt) 2018-09-26 2026-06-08 Medac Ges Fr Klinische Spezialprparate Mbh Liofilizado de treossulfano
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5830473A (en) * 1994-06-18 1998-11-03 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Antibodies against T cells as therapeutics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000045842A2 (en) * 1999-02-04 2000-08-10 The General Hospital Corporation Methods for human allografting

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5830473A (en) * 1994-06-18 1998-11-03 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Antibodies against T cells as therapeutics

Also Published As

Publication number Publication date
CA2389896A1 (en) 2001-05-10
ATE251455T1 (de) 2003-10-15
CZ20021562A3 (cs) 2002-10-16
BG65845B1 (bg) 2010-03-31
EP1227808B1 (de) 2003-10-08
NO2019032I1 (no) 2019-07-23
DE50004024D1 (de) 2003-11-13
EP1227808A2 (de) 2002-08-07
AU1391801A (en) 2001-05-14
WO2001032154A2 (de) 2001-05-10
DE19953517C1 (de) 2001-08-09
NO20022109L (no) 2002-07-01
US7199162B1 (en) 2007-04-03
PL212132B1 (pl) 2012-08-31
NO329616B1 (no) 2010-11-22
ES2208435T3 (es) 2004-06-16
EA004543B1 (ru) 2004-06-24
AU777527B2 (en) 2004-10-21
HUP0203277A2 (en) 2003-01-28
PL356240A1 (en) 2004-06-28
BG106772A (bg) 2003-02-28
NO20022109D0 (no) 2002-05-02
CA2389896C (en) 2007-04-10
UA73961C2 (uk) 2005-10-17
WO2001032154A3 (de) 2002-01-24
JP2003513034A (ja) 2003-04-08
JP4846151B2 (ja) 2011-12-28
EA200200535A1 (ru) 2002-10-31
HU227332B1 (en) 2011-03-28
HUS1900041I1 (hu) 2019-10-28

Similar Documents

Publication Publication Date Title
Capizzi The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (ethyol®)
JP7776435B2 (ja) シクロフィリン阻害剤およびその使用
EP2143429B1 (en) Use of cilastatin to reduce the nephrotoxicity of different compounds
CN1225287C (zh) 稳定的放射性药物组合物
EP0344880B1 (en) Pharmaceutical compositions with anti-cancer activity
UA127738C2 (uk) Проліки дантролену і способи їх застосування
WO2021190603A1 (en) Cyclophilin inhibitors and uses thereof
Upadhyay et al. Chemical radioprotectors
KR20130118981A (ko) 다형 교모세포종의 치료를 위한 마시텐탄 포함 조합물
CN100479814C (zh) 促淋巴细胞归巢剂在制备用于治疗移植物功能恢复延迟的药物中的用途
CZ20021562A3 (cs) Pouľití treosulfanu jako prostředku upravujícího předoperační stav pacienta před transplantací kostní dřeně nebo transplantací krevních kmenových buněk
MX2012000303A (es) Composiciones farmaceuticas y metodos teraputicos que emplean una combinacion de un compuesto complejo de manganeso y una forma compleja no de manganeso del compuesto.
KR20040038984A (ko) 암 치료 방법 및 암 치료용 조성물
US20040072801A1 (en) Sterols bearing pendant allosteric effectors of hemoglobin, and uses thereof
WO2000043403A1 (en) 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
RU2123348C1 (ru) Противолучевое средство
JPH08509961A (ja) 低密度リポタンパク質および細胞毒性物質の使用
CN102614180A (zh) 伊曲康唑在制备治疗多发性骨髓瘤药物中的应用
Ozturk et al. Acute myeloblastic leukemia achieving complete remission with amifostine alone
Hess et al. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
WO2025141294A1 (en) Novel hydrogen sulfide releasing compounds
Parsons Non-Immunophilin-Related Immunosuppressants
Renešová Cyclophosphamide effects on hematopoiesis
US20030228253A1 (en) Radiolabelled thioplatin, compositions thereof and methods of cancer treatment
Gulati Pharmacological mechanisms in the cardiovascular effects of DCLHb, a hemoglobin based blood substitute

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20251103